The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Neurocognitive Effects of Clozapine, Olanzapine, Risperidone, and Haloperidol in Patients With Chronic Schizophrenia or Schizoaffective Disorder
Abstract
OBJECTIVE: Newer antipsychotic drugs have shown promise in ameliorating neurocognitive deficits in patients with schizophrenia, but few studies have compared newer antipsychotic drugs with both clozapine and conventional agents, particularly in patients who have had suboptimal response to prior treatments. METHOD: The authors examined the effects of clozapine, olanzapine, risperidone, and haloperidol on 16 measures of neurocognitive functioning in a double-blind, 14-week trial involving 101 patients. A global score was computed along with scores in four neurocognitive domains: memory, attention, motor function, and general executive and perceptual organization. RESULTS: Global neurocognitive function improved with olanzapine and risperidone treatment, and these improvements were superior to those seen with haloperidol. Patients treated with olanzapine exhibited improvement in the general and attention domains but not more than that observed with other treatments. Patients treated with risperidone exhibited improvement in memory that was superior to that of both clozapine and haloperidol. Clozapine yielded improvement in motor function but not more than in other groups. Average effect sizes for change were in the small to medium range. More than half of the patients treated with olanzapine and risperidone experienced "clinically significant" improvement (changes in score of at least one-half standard deviation relative to baseline). These findings did not appear to be mediated by changes in symptoms, side effects, or blood levels of medications. CONCLUSIONS: Patients with a history of suboptimal response to conventional treatments may show cognitive benefits from newer antipsychotic drugs, and there may be differences between atypical antipsychotic drugs in their patterns of cognitive effects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Positive and Negative Syndrome Scale (PANSS) for schizophrenia.
Kay, S. R., Fiszbein, A., & Opler, L. A. (1987) · Schizophrenia Bulletin · doi:10.1093/schbul/13.2.261 · Cited by 21,378
The Quality of Life Scale: An Instrument for Rating the Schizophrenic Deficit Syndrome
Heinrichs, D. W., Hanlon, T. E., & Carpenter, W. T. (1984) · Schizophrenia Bulletin · doi:10.1093/schbul/10.3.388 · Cited by 1,688
The hopkins verbal learning test: Development of a new memory test with six equivalent forms
Brandt, J. (1991) · Clinical Neuropsychologist · doi:10.1080/13854049108403297 · Cited by 1,317 · cited 1×
“The specific tests used have been described extensively in prior research by us and others (1, 22, 23).”
MethodThe Effects of Clozapine, Risperidone, and Olanzapine on Cognitive Function in Schizophrenia
Meltzer, H. Y., & McGurk, S. R. (1999) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a033376 · Cited by 1,020
Neuropsychology of First-Episode Schizophrenia: Initial Characterization and Clinical Correlates
Bilder, R. M., Goldman, R. S., Robinson, D., Reiter, G., Bell, L., Bates, J. A., Pappadopulos, E., Willson, D. F., Alvir, J. M. J., Woerner, M. G., et al. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.4.549 · Cited by 906
Self-citationKeefe, R. S. E., Silva, S. G., Perkins, D. O., & Lieberman, J. A. (1999) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a033374 · Cited by 693
Self-citationThe Role of Serotonin in Antipsychotic Drug Action
Meltzer, H. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00046-9 · Cited by 662
Studies of Cognitive Change in Patients With Schizophrenia Following Novel Antipsychotic Treatment
Harvey, P. D., & Keefe, R. S. E. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.2.176 · Cited by 620
Purdon, S. E. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.3.249 · Cited by 469
Honigfeld, G., & Klett, C. J. (1965) · Journal of Clinical Psychology · doi:10.1002/1097-4679(196501)21:1<65::aid-jclp2270210122>3.0.co;2-i · Cited by 435
Volavka, J., Czobor, P., Sheitman, B., Lindenmayer, J.-P., Citrome, L., McEvoy, J. P., Cooper, T. B., Chakos, M., & Lieberman, J. A. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.2.255 · Cited by 407
Self-citationDoes risperidone improve verbal working memory in treatment-resistant schizophrenia?
(1997) · American Journal of Psychiatry · doi:10.1176/ajp.154.6.799 · Cited by 397
Relation of neuroleptic and anticholinergic medication to cognitive functions in schizophrenia.
Spohn, H. E., & Strauss, M. E. (1989) · Journal of Abnormal Psychology · doi:10.1037//0021-843x.98.4.367 · Cited by 381
Multiple Testing of General Contrasts Using Logical Constraints and Correlations
Westfall, P. H. (1997) · Journal of the American Statistical Association · doi:10.1080/01621459.1997.10473627 · Cited by 234
Bilder, R. M., Bogerts, B., Ashtari, M., Wu, H., Alvir, J. M., Jody, D., Reiter, G., Bell, L., & Lieberman, J. A. (1995) · Schizophrenia Research · doi:10.1016/0920-9964(95)00028-k · Cited by 181
Self-citationSerum levels of anticholinergic drugs and impaired recent memory in chronic schizophrenic patients
(1982) · American Journal of Psychiatry · doi:10.1176/ajp.139.11.1460 · Cited by 173
The Role of Serotonin in Antipsychotic Drug Action
Meltzer, H. Y. (1999) · Neuropsychopharmacology · doi:10.1038/sj.npp.1395370 · Cited by 164
Effects of anticholinergic medication on memory in schizophrenia
Strauss, M. E., Reynolds, K. S., Jayaram, G., & Tune, L. E. (1990) · Schizophrenia Research · doi:10.1016/0920-9964(90)90045-9 · Cited by 120
Meyer‐Lindenberg, A., Gruppe, H., Bauer, U., Lis, S., Krieger, S., & Gallhofer, B. (1997) · Pharmacopsychiatry · doi:10.1055/s-2007-979481 · Cited by 117
Catlow, J. T., Barton, R. D., Clements, M., Gillespie, T. A., Goodwin, M., & Swanson, S. P. (1995) · Journal of Chromatography B Biomedical Sciences and Applications · doi:10.1016/0378-4347(95)00061-m · Cited by 106
Neurocognitive Impairment in Schizophrenia and how it Affects Treatment Options
Bilder, R. M. (1997) · The Canadian Journal of Psychiatry · doi:10.1177/070674379704200303 · Cited by 85
Self-citationChengappa, K. N. R., Pollock, B. G., Parepally, H., Levine, J., Kirshner, M. A., Brar, J. S., & Zoretich, R. A. (2000) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200006000-00004 · Cited by 75
Bianchetti, G., & Morselli, P. L. (1978) · Journal of Chromatography A · doi:10.1016/s0021-9673(00)89873-8 · Cited by 74
The effects of clozapine on neurocognition: an overview.
Goldberg, T. E., & Weinberger, D. R. (1994) · PubMed · Cited by 68
Christensen, B. K., & Bilder, R. M. (2000) · The Canadian Journal of Psychiatry · doi:10.1177/070674370004500303 · Cited by 56
Self-citationLencz, T., PhD, Cornblatt, B., PhD, Bilder, A. R. M., & PhD (2025) · Psychopharmacology Bulletin · doi:10.64719/pb.4274 · Cited by 28
Cited by
Cognitive Function Across Manic or Hypomanic, Depressed, and Euthymic States in Bipolar Disorder
Martínez-Arán, A., Vieta, E., Reinares, M., Colom, F., Torrent, C., Sánchez-Moreno, J., Benabarre, A., Goikolea, J. M., Comes, M., & Salamero, M. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.2.262 · Cited by 1,103
Keefe, R. S. E. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.6.633 · Cited by 1,065
Miyamoto, S., Duncan, G. E., Marx, C. E., & Lieberman, J. A. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001556 · Cited by 988
Self-citationCognitive deficits and functional outcome in schizophrenia
Bowie, C. R., & Harvey, P. D. (2006) · Neuropsychiatric Disease and Treatment · doi:10.2147/nedt.2006.2.4.531 · Cited by 647
Hasan, A., Falkai, P., Wobrock, T., Lieberman, J., Glenthoj, B., Gattaz, W. F., Thibaut, F., Möller, H.-J., & the Wfsbp Task Force on Treatment Guidelines for Schizophrenia (2012) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2012.696143 · Cited by 637
Self-citation
Metadata
- Authors
- Bilder, R. M., Goldman, R. S., Volavka, J., Czobor, P., Hoptman, M., Sheitman, B., Lindenmayer, J.-P., Citrome, L., McEvoy, J., Kunz, M., Chakos, M., Cooper, T. B., Horowitz, T. L., & Lieberman, J. A.
- Venue
- American Journal of Psychiatry
- Published
- 2002-06-01
- Volume
- 159
- Issue
- 6
- Pages
- 1018-1028
- ISSN
- 0002-953X (ISSN-L)
- 1535-7228
- OpenAlex
- W2149805979
- Cited by
- 538
- References
- 26
- FWCI
- 31.31
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.